Neoantigen mRNA vaccines are highly effective against gastric cancer with peritoneal metastasis (IMAGE)

Kindai University

Neoantigen mRNA vaccines are highly effective against gastric cancer with peritoneal metastasis

Caption

Neoantigen (tumor-specific antigen) mRNA-based vaccines induce progenitor‑exhausted T cells that support anti‑PD‑1 therapy, leading to enhanced antitumor efficacy against gastric cancer, which has metastasized to the peritoneum (i.e., the lining of the abdominal cavity).

Credit

Professor Kazuhiro Kakimi from Kindai University, Japan

Usage Restrictions

Credit must be given to the creator.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.